Article Details

Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with ...

Retrieved on: 2022-04-25 12:08:52

Tags for this article:

Click the tags to see associated articles and topics

Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with .... View article details on hiswai:

Excerpt

PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR), a commercial-stage biopharmaceutical company focused on the development of ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up